Joanne T. Beck's most recent trade in Astria Therapeutics Inc was a trade of 26,550 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Astria Therapeutics Inc | Joanne T. Beck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 26,550 | 26,550 | - | - | Stock Option (Right to Buy) | |
| Astria Therapeutics Inc | Joanne T. Beck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 14,100 | 14,100 | - | - | Stock Option (Right to Buy) | |
| Astria Therapeutics Inc | Joanne T. Beck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2023 | 14,100 | 14,100 | - | - | Stock Option (Right to Buy) | |
| Astria Therapeutics Inc | Joanne T. Beck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 8,333 | 8,333 | - | - | Stock Option (right to buy) | |
| Astria Therapeutics Inc | Joanne T. Beck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 100,000 | 100,000 | - | - | Stock Option (right to buy) |